NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024
Mary B. Daly(Fox Chase Cancer Center), Susan Darlow(National Comprehensive Cancer Network), Matthew B. Yurgelun(Dana-Farber Cancer Institute), Gwen Reiser(University of California San Diego), Marie Wood(University of Colorado Cancer Center), Zahraa Al‐Hilli(Cleveland Clinic), Christine Laronga(Moffitt Cancer Center), Banu Arun(The University of Texas Health Science Center at Houston), Dominique Rash(UC San Diego Health System), Andrea R. Hagemann(Gynecologic Oncology Group), Tuya Pal(Vanderbilt University Medical Center), Carolyn S. Menendez(Memorial Sloan Kettering Cancer Center), Katia Khoury(University of Colorado Cancer Center), Heather H. Cheng(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kristen M. Shannon(Massachusetts General Hospital), John C. Mansour(Southwestern Medical Center), Leigha Senter-Jamieson(City Of Hope National Medical Center), Wendy Kohlmann(University of Utah), Kara N. Maxwell(Philadelphia VA Medical Center), Susan M. Domchek(University City Science Center), Allison W. Kurian(Stanford University), Nawal Kassem(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Sofía D. Merajver(University of Michigan), Myra Wick(WinnMed), Saundra S. Buys(University of Utah), Veda N. Giri(Yale Cancer Center), Beth Y. Karlan(University of California, Los Angeles), Mollie L. Hutton(Roswell Park Comprehensive Cancer Center), Ashley Hendrix(St. Jude Children's Research Hospital), Kala Visvanathan(Johns Hopkins University), Michael Goggins(Johns Hopkins University), Jane Churpek(University of Wisconsin–Madison), Kevin McDonnell(City Of Hope National Medical Center), Jeanna Welborn(UC Davis Comprehensive Cancer Center), Susan Friedman(Facing Our Risk of Cancer Empowered), Mary A. Dwyer(National Comprehensive Cancer Network), Kenneth Offit(Memorial Sloan Kettering Cancer Center), Seema Khan(University of Colorado Cancer Center), Julie Mak(University of Michigan)
Cited by 284
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k